Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2021-11-10 | New | $214,999,926 | $214,999,926 | Equity Only | 06b | SEC link |
| 2017-08-02 | Amended | $15,599,998 | $3,374,999 | Equity Only | 06b | SEC link |
| 2017-06-01 | New | $12,224,999 | $12,224,999 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark Angelino | Director |
| David Cheng | Executive |
| Keith Crandell | Director |
| Rami Harawi | Director |
| Annie Hazlehurst | Director |
| Paul Meister | Director |
| Kelly Morgan | Executive |
| John Murphy | Executive |
| David Arthur Scott | Executive |
| Devyn Smith | Director, Executive |
| Pam Stetkiewicz | Executive |
| David Walt | Director |
| Winston Xia Yan | Executive |
| Chen Yu | Director |
| Feng Zhang | Director |